BIOMAT Database Logo BIOMAT Database Logo

[Pharmacological protection of the kidneys from ischemic damage. The effectiveness of anti-ischemia protection of the kidneys in simulating the terminal state in the donors]. 1982

V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia

UI MeSH Term Description Entries
D007022 Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients. Blood Pressure, Low,Hypotension, Vascular,Low Blood Pressure,Vascular Hypotension
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D010431 Pentoxifylline A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. Agapurin,BL-191,Oxpentifylline,Pentoxil,Torental,Trental,BL 191,BL191
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003643 Death Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions. End Of Life,End-Of-Life,Near-Death Experience,Cardiac Death,Determination of Death,Death, Cardiac
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug

Related Publications

V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia
[Pharmacologic protection of the kidneys from ischemic damage].
January 1979, Vestnik Akademii meditsinskikh nauk SSSR,
V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia
Pharmacological protection of rabbit kidneys from normothermic ischemia.
August 1979, Transplantation,
V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia
[Mechanism of the anti-ischemic protection of the kidneys by diuretics].
January 1986, Farmakologiia i toksikologiia,
V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia
[Pharmacological protection of the liver from ischemia].
January 1987, Anesteziologiia i reanimatologiia,
V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia
[The mechanism of the anti-ischemic protection of the kidneys by diuretics].
January 1991, Farmakologiia i toksikologiia,
V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia
Pharmacologic protection of rabbit kidneys from normothermic ischemia.
January 1979, Current surgery,
V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia
Use of kidneys from anti-HCV positive donors.
January 2001, Transplantation proceedings,
V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia
Transplantation of kidneys from Anti-HCV positive donors.
January 2001, Transplantation proceedings,
V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia
Protection of kidneys from acute renal failure resulting from normothermic ischemia.
July 1983, Laboratory investigation; a journal of technical methods and pathology,
V I Kirpatovskiĭ, and N A Onishchenko, and A A Lubiako, and M A Danilov, and T A Bogoiavlenskaia
Successful transplantation of kidneys from deceased donors with terminal acute kidney injury.
November 2019, Renal failure,
Copied contents to your clipboard!